JUNO THERAPEUTICS ORD SHS/ US48205A1097 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
3:30 PM
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
3:00 PM
Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Trea...
GlobeNewswire
2:45 PM
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of i...
GlobeNewswire
2:00 PM
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Im...
GlobeNewswire
2:00 PM
AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire
2:00 PM
Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
GlobeNewswire
2:00 PM
Panbela Announces Poster Presentation at American Association for Cancer Research:
GlobeNewswire
1:30 PM
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with B...
GlobeNewswire
1:30 PM
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple ...
GlobeNewswire
1:30 PM
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewswire
1:00 PM
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
GlobeNewswire
1:00 PM
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the P...
GlobeNewswire
1:00 PM
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million
GlobeNewswire
1:00 PM
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product
GlobeNewswire
1:00 PM
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Tar...
GlobeNewswire
12:30 PM
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial fo...
GlobeNewswire
12:00 PM
Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain &...
GlobeNewswire
12:22 AM
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Couns...